In particular, upregulated AXL mRNA expression has been observed in ccRCC, where it is associated with worse overall survival (OS) and can serve as an independent predictor of prognosis in ccRCC patients [12]. This evidence concerns the gene AXL and nonpapillary renal cell carcinoma.